ArriVent BioPharma (AVBP) Other Non-Current Assets (2023 - 2026)
ArriVent BioPharma (AVBP) reported Other Non-Current Assets of $156000.0 for Q1 2026, down 11.36% on a YoY basis from $176000.0 in Q1 2025, and down 17.89% sequentially from $190000.0 in Q4 2025.
ArriVent BioPharma (AVBP) Other Non-Current Assets (2023 - 2026) Analysis & Trends
ArriVent BioPharma (AVBP) has 4 years of Other Non-Current Assets data on file, last reported at $156000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 11.36% year-over-year to $156000.0; the trailing twelve-month figure through Mar 2026 stood at $156000.0 (down 11.36% YoY), and the FY2025 full-year result was $190000.0, up 50.79% from the prior year.
- Other Non-Current Assets fell to $156000.0 in Q1 2026, from $190000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $479000.0 in Q2 2025 to a low of $107000.0 in Q4 2023.
- A 4-year average of $177300.0 and a median of $141000.0 in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets soared 283.2% in 2025 and declined 11.36% in 2026, its largest moves.
- Tracing AVBP's Other Non-Current Assets over 4 years: stood at $107000.0 in 2023, then rose by 17.76% to $126000.0 in 2024, then soared by 50.79% to $190000.0 in 2025, then decreased by 17.89% to $156000.0 in 2026.
- Business Quant data shows AVBP's Other Non-Current Assets at $156000.0 in Q1 2026, $190000.0 in Q4 2025, and $180000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | ArriVent BioPharma | 1.42 Bn | 1.42 Bn | - | 156,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156,000.00 |
| Dec 31, 2025 | 190,000.00 |
| Sep 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 479,000.00 |
| Mar 31, 2025 | 176,000.00 |
| Dec 31, 2024 | 126,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 125,000.00 |
| Mar 31, 2024 | 108,000.00 |
| Dec 31, 2023 | 107,000.00 |